Dr. Donner's clinical and research interests include aggressive management of type 1 and type 2 diabetes, preserving beta cell function in patients with new onset type 1 diabetes, and the prevention of diabetes complications.
1. 1R01AI099027-01 NIH/NIAID Hamad (PI) 03/01/13 - 03/31/18
Mechanisms of Fas Ligand control of insulitis initiation in autoimmune diabetes
2. NIDDK Donner (PI) 05/13 – present
The Natural History Study of the Development of Type 1 Diabetes
3. NovoNordisk Donner (PI) 10/13 - present
Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 Diabetes